Sivia Capital Partners LLC Invests $306,000 in HealthEquity, Inc. $HQY

Key Points

• Sivia Capital Partners LLC has acquired 2,919 shares of HealthEquity, Inc. during the 2nd quarter, valued at approximately $306,000.
• Several analysts have raised their price targets for HealthEquity, with a consensus target now at $119.77 and a majority rating the stock as a "Buy."
• Executive Vice President Michael Henry Fiore sold 1,794 shares of HealthEquity, reducing his stake by 3.26%, while still holding approximately $5.41 million in shares.

Sivia Capital Partners LLC purchased a new stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 2,919 shares of the company's stock, valued at approximately $306,000.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HQY. Versant Capital Management Inc bought a new stake in HealthEquity during the first quarter valued at approximately $28,000. WPG Advisers LLC bought a new stake in shares of HealthEquity during the 1st quarter valued at $28,000. Northwestern Mutual Wealth Management Co. increased its stake in shares of HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock worth $58,000 after purchasing an additional 418 shares in the last quarter. Larson Financial Group LLC raised its holdings in HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock worth $61,000 after purchasing an additional 642 shares during the period. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new position in HealthEquity in the 1st quarter worth $65,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

HealthEquity Price Performance

Shares of HQY stock traded up $2.23 during mid-day trading on Monday, hitting $95.97. The company had a trading volume of 859,094 shares, compared to its average volume of 1,243,952. HealthEquity, Inc. has a 52-week low of $74.07 and a 52-week high of $116.65. The stock's 50 day moving average price is $92.82 and its 200-day moving average price is $93.91. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a market capitalization of $8.27 billion, a P/E ratio of 58.16, a P/E/G ratio of 1.34 and a beta of 0.50.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on HQY. Deutsche Bank Aktiengesellschaft upped their price target on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a research report on Thursday, June 5th. JMP Securities raised their target price on shares of HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a research note on Wednesday, June 4th. Barrington Research reaffirmed an "outperform" rating and set a $125.00 price target on shares of HealthEquity in a report on Friday, August 29th. JPMorgan Chase & Co. increased their price objective on shares of HealthEquity from $125.00 to $126.00 and gave the stock an "overweight" rating in a research note on Wednesday, September 3rd. Finally, Wall Street Zen upgraded shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $119.77.

Insider Buying and Selling at HealthEquity

In other HealthEquity news, EVP Delano Ladd sold 6,000 shares of the stock in a transaction dated Friday, September 19th. The shares were sold at an average price of $94.11, for a total transaction of $564,660.00. Following the completion of the transaction, the executive vice president owned 79,456 shares of the company's stock, valued at $7,477,604.16. This represents a 7.02% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of HealthEquity stock in a transaction dated Monday, July 7th. The stock was sold at an average price of $101.73, for a total value of $182,503.62. Following the completion of the sale, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. This trade represents a 3.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.50% of the stock is owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.